Frontiers in Pharmacology (Jul 2020)
Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study
- Narmeen Mallah,
- Narmeen Mallah,
- Maruxa Zapata-Cachafeiro,
- Maruxa Zapata-Cachafeiro,
- Carmelo Aguirre,
- Carmelo Aguirre,
- Carmelo Aguirre,
- Eguzkiñe Ibarra-García,
- Eguzkiñe Ibarra-García,
- Itziar Palacios-Zabalza,
- Itziar Palacios-Zabalza,
- Fernando Macías-García,
- J. Enrique Domínguez-Muñoz,
- María Piñeiro-Lamas,
- María Piñeiro-Lamas,
- Luisa Ibáñez,
- Xavier Vidal,
- Lourdes Vendrell,
- Luis Martin-Arias,
- María Sáinz-Gil,
- Verónica Velasco-González,
- Adolfo Figueiras,
- Adolfo Figueiras,
- Adolfo Figueiras
Affiliations
- Narmeen Mallah
- Department of Preventive Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
- Narmeen Mallah
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Carlos III Health Institute, Madrid, Spain
- Maruxa Zapata-Cachafeiro
- Department of Preventive Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
- Maruxa Zapata-Cachafeiro
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Carlos III Health Institute, Madrid, Spain
- Carmelo Aguirre
- Biocruces Bizkaia Health Research Institute, Pharmacotherapy Group, Bizkaia, Spain
- Carmelo Aguirre
- University Hospital of Galdakao-Usansolo. Basque Country Pharmacovigilance Unit, Osakidetza, Spain
- Carmelo Aguirre
- Pharmacology Department, Medicine and Nursing Faculty, University of the Basque Country, Barakaldo, Bizkaia, Spain
- Eguzkiñe Ibarra-García
- Biocruces Bizkaia Health Research Institute, Pharmacotherapy Group, Bizkaia, Spain
- Eguzkiñe Ibarra-García
- Osakidetza Basque Health Service, Urduliz Hospital, Pharmacy Department, Urduliz, Spain
- Itziar Palacios-Zabalza
- Biocruces Bizkaia Health Research Institute, Pharmacotherapy Group, Bizkaia, Spain
- Itziar Palacios-Zabalza
- University Hospital of Galdakao-Usansolo. Basque Country Pharmacovigilance Unit, Osakidetza, Spain
- Fernando Macías-García
- Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
- J. Enrique Domínguez-Muñoz
- Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
- María Piñeiro-Lamas
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Carlos III Health Institute, Madrid, Spain
- María Piñeiro-Lamas
- Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
- Luisa Ibáñez
- Department of Pharmacology, Therapeutics and Toxicology, Catalonian Institute of Pharmacology, Clinical Pharmacology Service, Vall d’Hebron University Teaching Hospital, Autonomous University, Barcelona, Spain
- Xavier Vidal
- Department of Pharmacology, Therapeutics and Toxicology, Catalonian Institute of Pharmacology, Clinical Pharmacology Service, Vall d’Hebron University Teaching Hospital, Autonomous University, Barcelona, Spain
- Lourdes Vendrell
- Department of Pharmacology, Therapeutics and Toxicology, Catalonian Institute of Pharmacology, Clinical Pharmacology Service, Vall d’Hebron University Teaching Hospital, Autonomous University, Barcelona, Spain
- Luis Martin-Arias
- 0Centre for Research on Drug Safety (CESME), Valladolid University, Valladolid, Spain
- María Sáinz-Gil
- 0Centre for Research on Drug Safety (CESME), Valladolid University, Valladolid, Spain
- Verónica Velasco-González
- 0Centre for Research on Drug Safety (CESME), Valladolid University, Valladolid, Spain
- Adolfo Figueiras
- Department of Preventive Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
- Adolfo Figueiras
- Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Carlos III Health Institute, Madrid, Spain
- Adolfo Figueiras
- Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
- DOI
- https://doi.org/10.3389/fphar.2020.01072
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
- aspirin
- upper gastrointestinal haemorrhage
- genetic polymorphism
- pharmacogenomics
- platelet
- interaction